Irish Drug Maker Settles Charges of Improper Marketing - New York Times
Irish Drug Maker Settles Charges of Improper MarketingNew York TimesThe Japanese drug maker Eisai also agreed to pay $11 million to resolve a civil case for off-label marketing of Zonegran after it bought rights to the drug ...and more��
Blog Content
No comments:
Post a Comment